Please assess the completion status of the following clinical trial:

Trial Title: EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Be an adult over 18 years of age~* Have a free fibular graft placed more than six months ago that has been used for restoration of mandibular continuity.~* Be in need of surgery to increase the vestibular fold of the grafted mandible for placement of a dental prosthesis to restore function~Exclusion Criteria:~* Any liver, kidney, heart, blood, metabolic or systemic disease which may make execution of the protocol of interpretation of the results difficult~* A history of syphilis, HIV, Hepatitis B or Hepatitis C~* Pregnancy or planning to become pregnant~* Known or suspected allergy to bovine (cow) protein~* Receiving radiation~* Currently smoking or using tobacco products~* Talking medication that can result in gingival enlargement (Cyclosporine, Dilantin, calcium channel blockers)~* Allergy to any of the following antibiotics Gentamycin, Cefoxitin, Lincomycin, Polymyxin B, Vancomycin, cephalosporins, or clindamycin~* Allergy to Polysorbate 20

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AlloDerm (Type: ACTIVE_COMPARATOR): The subject will be treated with the standard of care, AlloDerm, to cover the defect in the mouth.
- EVPOME (Type: EXPERIMENTAL): An ex-vivo produced oral mucose equivalent (EVPOME) will be used to cover the defect in the top of the mouth.

Based on this trial design, predict the completion outcome and termination type (if applicable).